Abstract:In this study, we aimed to construct an effective and safe oncolytic adenoviral vector for cancer treatment with gene therapy. First, the promoter of the catalytic subunit of human telomerase (hTERTp), adenovirus early region 1a gene (E1A) and thymidine kinase gene of human herpes virus type 1 (HSV-1-TK) were amplified by using PCR from genomic DNA of 293A cells and wild-type HSV-1 (wHSV-1). These specially-prepared elements were inserted into an adenoviral shuttle vector in the opposite and the same directions of left inverted terminal repeat (L-ITR), respectively, to construct pENTR-E1A-IRES-TK-hTERTp (pEITH) and pENTR-hTERTp-E1A-IRES-TK (pHEIT). LR reaction between adenoviral shuttle vectors (pEITH and pHEIT) and the backbone vector DEST was carried out to establish adenoviral expression vectors pAd-E1A-IRES-TK-hTERTp (pAd-EITH) and pAd-hTERTp-E1A-IRES-TK (pAd-HEIT). Recombinant adenovirus Ad-EITH and Ad-HEIT were produced by transfecting 293A cells and purified for the subsequent studies of titer measurement, replication capability with and without acyclovir (ACV) and antitumor ability with and without ganciclovir (GCV) to evaluate the biological characteristics. Adenoviral shuttle vectors pEITH and pHEIT and expression vectors pAd-EITH and pAd-HEIT were successfully constructed, and recombinant adenoviruses Ad-EITH and Ad-HEIT with high titer were produced. The results of replication and cytotoxicity assays showed that Ad-EITH and Ad-HEIT replicated in the hTERTp (+) human nasopharyngeal carcinoma cell line CNE and expressed the TK gene effectively leading to the death of tumor cells. In addition, there were still some Ad-HEIT particles replicating in the hTERTp (-) human osteosarcoma U-2OS cells and human lung HFL-1 fibroblasts compared to Ad-EITH which was hardly able to replicate in U-2OS and HFL-1 cells. In addition, we also observed an interesting phenomenon, that the replication of Ad-EITH could be inhibited by antiviral drug ACV on account of the expression of HSV-1-TK gene making Ad-EITH sensitive to ACV. In conclusion, a novel oncolytic adenoviral vector Ad-EITH was produced which can be used for cancer-specific and efficient viral replication, and its safety is potentially improved as replication can be inhibited by ACV in vitro.

[Tumor-selective replication, cytotoxicity and GM-CSF production of oncolytic recombinant adenovirus in KH901 injection]

E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.

A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.

RESEARCH ON DISSEMINATION OF RECOMBINANT ADENOVIRUS INTRA-TUMOR INJECTION IN HUMAN BODY

An Immune-Competent, Replication-Permissive Syrian Hamster Glioma Model for Evaluating Delta-24-RGD Oncolytic Adenovirus.

Killing Effect of TNF-mediated by Conditionally Replicating Adenovirus on Esophageal Cancer and Lung Cancer Cell Lines.

Tumor-specific Oncolytic Adenoviruses Expressing Granulocyte Macrophage Colony-Stimulating Factor or Anti-Ctla4 Antibody for the Treatment of Cancers

An Oncolytic Adenovirus Expressing Granulocyte Macrophage Colony-Stimulating Factor Shows Improved Specificity and Efficacy for Treating Human Solid Tumors

An Oncolytic Adenovirus Expressing Herpes Simplex Virus-Thymidine Kinase for Targeting Cancer Therapy: an in Vitro Evaluation

A Conditionally Replicating Adenovirus CNHK500 for the Treatment of Breast Cancer

Inhibitory Effect of 5/35 Chimeric Oncolytic Adenovirus SG635 on Hepatocarcinoma Cells

Biodistribution and Kinetics of the Novel Selective Oncolytic Adenovirus M1 after Systemic Administration

An in Vitro Study of a Conditionally Replicative Adenovirus Delivering the Herpes Simplex Virus Thymidine Kinase Suicide Gene in Retinoblastoma

Construction and Characterization of Oncolytic Adenovirus Controlled under Heat Shock Protein70 Gene Promoter*

Construction of a Novel Oncolytic Adenoviral Vector and Its Biological Characteristics

Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer

[Antitumor Effects of Radioiodine Labeled KH901 on Nude Mice Bearing Hepatoma].

[Experimental Study on Human Pulmonary Adenocarcinoma Cell A549 Transfected with HSV₁-TK Gene in Vitro and in Vivo].

Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI.3B promoter

Adenovirus 5 E1a-Mediated Gene Therapy for Human Ovarian Cancer Cells in Vitro and in Vivo

Phase I and Biodistribution Study of Recombinant Adenovirus Vector-Mediated Herpes Simplex Virus Thymidine Kinase Gene and Ganciclovir Administration in Patients with Head and Neck Cancer and Other Malignant Tumors